Clinical Trials Browser

Uterine Cervical Neoplasms

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Phase 2 Not yet recruiting

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05879926 2026-03-03

OFSET

Phase 3 Recruiting

3,960 enrolled

Breast

Breast Neoplasms

NCT07184047 2026-02-20

TOX-FRAIL

Completed

72 enrolled

Gastrointestinal

Frailty, Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Malnutrition, Sarcopenia, Sarcoglycanopathies

NCT07423611 2026-02-20

RACE

Phase 2 Not yet recruiting

388 enrolled

Breast

Breast Neoplasms

NCT07413146 2026-02-17

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Phase NA Not yet recruiting

100 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

NCT02662504 2026-02-05

MesoPDT

Phase 2 Completed

6 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT03748485 2026-01-28

CANWATCH

Phase NA Recruiting

650 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

ACCRAPAN

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

OFSET

TOX-FRAIL

RACE

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

MesoPDT

CANWATCH